CARDLYTICS, INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 |
|---|---|---|---|
| Revenue | $150.7M | $130.4M | $112.8M |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin | — | — | — |
| Operating Expenses | |||
| Research & Development | $16.2M | $12.2M | $13.9M |
| SG&A Expense | $34.2M | $20.1M | $21.4M |
| Operating Income | $-40.9M | $-17.1M | $-56.2M |
| Operating Margin | -27.2% | -13.1% | -49.8% |
| Interest Expense | — | — | — |
| Pretax Income | $-53.0M | $-19.6M | $-75.7M |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income | $-53.0M | $-19.6M | $-75.7M |
| Net Margin | -35.2% | -15.1% | -67.1% |
| EPS (Basic) | $-2.79 | $-7.86 | $-32.48 |
| EPS (Diluted) | $-2.79 | $-7.86 | $-32.48 |
| Shares Outstanding (Basic) | 22.5M | 3.4M | — |
| Shares Outstanding (Diluted) | 22.5M | 3.4M | — |
| Dividends Per Share | — | — | — |